Search
for
Sort by
Research 31–60 of 1000+
- Frontal fibrosing alopecia: a disease that remains enigmatic
- Alopecia Areata after COVID-19 Vaccines
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Ophthalmologic Comorbidities in Alopecia Areata
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- Stem-cell therapy in dermatology – Challenges and opportunities
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice
- The potential of regulatory T cell-based therapies for alopecia areata
- Immunological Abnormalities In PCOS
- Finasteride and the hair cycle
- MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Symptom management in inflammatory bowel disease
- Transplantation of melanocyte stem cells in vitiliginous skin
- Vaccines, adjuvants and autoimmunity
- 219 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
- Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
- Dermatological complications due to post‑COVID‑19 syndrome: A systematic review
- Long COVID syndrome: An unfolding enigma
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Aldesleukin
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica